Key result
Genetic testing for severe hypertriglyceridemia identifies FCS in ~13% of patients, often involving non-LPL variants.
Why the study?
Familial chylomicronemia syndrome is a rare autosomal recessive disorder, and this study aimed to analyze the genotype distribution of FCS-causing genes in the United Kingdom.
Observational (n=880)
Yes
The genetic architecture of familial chylomicronemia syndrome in the UK is highly diverse, with nearly half of cases driven by non-LPL gene variants, highlighting the importance of comprehensive genetic panels for severe hypertriglyceridemia.
Supports selective genetic testing in severe hypertriglyceridemia; leaves open the clinical impact of non-LPL variants.
Purpose: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder. This study aimed to analyze the genotype distribution of FCS-causing genes in the United Kingdom. Methods: Data were anonymously collated from 2 genetic testing laboratories providing national genetic diagnosis services for severe hypertriglyceridemia in the United Kingdom. Conclusion: FCS-causing genes. It also displays a significant regional and ethnic variations.
No takes yet. Share an insight, caveat, or question.
Bashir et al. (2025) conducted an observational in Severe hypertriglyceridemia / suspected familial chylomicronemia syndrome (FCS) (n=880). Pathogenic/likely pathogenic variants in FCS-causing genes vs. Variant negative individuals was evaluated on Detection rate of genetically proven familial chylomicronemia syndrome (FCS). Among 880 individuals tested for severe hypertriglyceridemia in the UK, 12.9% received a genetic diagnosis of familial chylomicronemia syndrome, with 45.6% of those harboring non-LPL variants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: